Concepedia

David Fairman

DF

22

Publications

1.7K

Citations

18

H-Index

1946

Active since

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

GlaxoSmithKline (United Kingdom)

Age UK

David Fairman is an author at Pfizer (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1946–2022

22

Publications

22

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Akram Khan, Cody Benthin, Brian Zeno et al. · Critical Care · 2017 · 618 citations · Full text

Contralateral, ipsilateral, and bilateral representation of cutaneous receptors in somatic areas I and II of the cerebral cortex of pig, sheep, and other mammals.

Clinton N. Woolsey, David Fairman · PubMed · 1946 · 293 citations

, , +11

The Antianginal Agent Trimetazidine Does Not Exert Its Functional Benefit via Inhibition of Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase

Alan MacInnes, David Fairman, Peter Binding et al. · Circulation Research · 2003 · 124 citations · Full text

, , +19

Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease

David S. Millan, Mark E. Bunnage, Jane L. Burrows et al. · Journal of Medicinal Chemistry · 2011 · 94 citations · Full text

, , +16

Free Drug Theory – No Longer Just a Hypothesis?

Scott Summerfield, James Yates, David Fairman · Pharmaceutical Research · 2022 · 86 citations

, , +2

Rows per page

1–5 of 22